U.S. Pharmaceutical Sterility Testing Market Size & Outlook
U.S. pharmaceutical sterility testing market, 2018-2030 (US$M)
Related Markets
U.S. pharmaceutical sterility testing market highlights
- The U.S. pharmaceutical sterility testing market generated a revenue of USD 573.4 million in 2023 and is expected to reach USD 1,142.4 million by 2030.
- The U.S. market is expected to grow at a CAGR of 10.3% from 2024 to 2030.
- In terms of segment, outsourcing was the largest revenue generating type in 2023.
- Outsourcing is the most lucrative type segment registering the fastest growth during the forecast period.
Pharmaceutical sterility testing market data book summary
| Market revenue in 2023 | USD 573.4 million |
| Market revenue in 2030 | USD 1,142.4 million |
| Growth rate | 10.3% (CAGR from 2023 to 2030) |
| Largest segment | Outsourcing |
| Fastest growing segment | Outsourcing |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | In-House, Outsourcing |
| Key market players worldwide | Steris PLC, Sotera Health Co Ordinary Shares, Sartorius AG, Solvias, SGS AG, Labcorp Holdings Inc, Pace Analytical Services, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc, Rapid Micro Biosystems Inc Class A, Almac Group, Pacific BioLabs, Inc., Boston Analytical, Labor LS |
Other key industry trends
- In terms of revenue, U.S. accounted for 36.0% of the global pharmaceutical sterility testing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. pharmaceutical sterility testing market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 462.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pharmaceutical Sterility Testing Market Scope
Pharmaceutical Sterility Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. pharmaceutical sterility testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical sterility testing market will help companies and investors design strategic landscapes.
Outsourcing was the largest segment with a revenue share of 58.91% in 2023. Horizon Databook has segmented the U.S. pharmaceutical sterility testing market based on in-house, outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
An increase in R&D activities and a rise in the number of drug approvals in the country are among the major factors supporting the market growth.
Moreover, the demand for medicines and effective treatment options is constantly growing due to the high prevalence of arthritis, asthma, diabetes, & other chronic diseases in the country, which is contributing to the growth of the U.S. pharmaceutical sterility testing market.
The U.S. FDA is actively involved in improving R&D funding in healthcare. For instance, in March 2023, the U.S. FDA requested USD 7.2 billion from the government as part of the president’s Fiscal Year (FY) 2024 budget.
Reasons to subscribe to U.S. pharmaceutical sterility testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. pharmaceutical sterility testing market databook
-
Our clientele includes a mix of pharmaceutical sterility testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. pharmaceutical sterility testing market , including forecasts for subscribers. This country databook contains high-level insights into U.S. pharmaceutical sterility testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. pharmaceutical sterility testing market size, by type, 2018-2030 (US$M)
U.S. Pharmaceutical Sterility Testing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
